Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-10

Clinical Trial Update: Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine [Phase 4]

View source ↗

Summary

Phase 4 maintenance-therapy trial comparing telbivudine to lamivudine in chronic hepatitis B patients with undetectable HBV DNA after initial telbudivudine trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)
  • Telbivudine (telbivudine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hepatitis, Chronic | Phase 4 | Status: TERMINATED